SUPPORT Tools for evidence-informed health Policymaking (STP) 2: Improving how your organisation supports the use of research evidence to inform policymaking by Oxman, Andrew D et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Health Research Policy and Systems
Open Access Guide
SUPPORT Tools for evidence-informed health 
Policymaking (STP) 2: Improving how your organisation supports 
the use of research evidence to inform policymaking
Andrew D Oxman*1, Per Olav  Vandvik2, John N Lavis3, Atle Fretheim4 and 
Simon Lewin5
Address: 1Norwegian Knowledge Centre for the Health Services, P.O. Box 7004, St. Olavs plass, N-0130 Oslo, Norway, 2Norwegian Knowledge 
Centre for the Health Services, P.O. Box 7004, St. Olavs plass,  N-0130 Oslo, Norway and Department of Medicine, Innlandet Hospital Health 
Authority, Gjøvik, Norway, 3Centre for Health Economics and Policy Analysis, Department of Clinical Epidemiology and Biostatistics, and 
Department of Political Science, McMaster University, 1200 Main St. West, HSC-2D3, Hamilton, ON, Canada, L8N 3Z5, 4Norwegian Knowledge 
Centre for the Health Services, P.O. Box 7004, St. Olavs plass, N-0130 Oslo, Norway; Section for International Health, Institute of General Practice 
and Community Medicine, Faculty of Medicine, University of Oslo, Norway and 5Norwegian Knowledge Centre for the Health Services, P.O. Box 
7004, St. Olavs plass, N-0130 Oslo, Norway; Health Systems Research Unit, Medical Research Council of South Africa
Email: Andrew D Oxman* - oxman@online.no; Per Olav  Vandvik - per.vandvik@start.no; John N Lavis - lavisj@mcmaster.ca; 
Atle Fretheim - atle.fretheim@nokc.no; Simon Lewin - simon.lewin@nokc.no
* Corresponding author    
Abstract
This article is part of a series written for people responsible for making decisions about health policies and
programmes and for those who support these decision makers.
In this article, we address ways of organising efforts to support evidence-informed health
policymaking. Efforts to link research to action may include a range of activities related to the
production of research that is both highly relevant to – and appropriately synthesised for –
policymakers. Such activities may include a mix of efforts used to link research to action, as well as
the evaluation of such efforts. Little is known about how best to organise the range of activity
options available and, until recently, there have been relatively few organisations responsible for
supporting the use of research evidence in developing health policy. We suggest five questions that
can help guide considerations of how to improve organisational arrangements to support the use
of research evidence to inform health policy decision making. These are: 1. What is the capacity of
your organisation to use research evidence to inform decision making? 2. What strategies should
be used to ensure collaboration between policymakers, researchers and stakeholders? 3. What
strategies should be used to ensure independence as well as the effective management of conflicts
of interest? 4. What strategies should be used to ensure the use of systematic and transparent
methods for accessing, appraising and using research evidence? 5. What strategies should be used
to ensure adequate capacity to employ these methods?
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About STP
This article is part of a series written for people responsible for
making decisions about health policies and programmes and for
those who support these decision makers. The series is intended
to help such people ensure that their decisions are well-informed
by the best available research evidence. The SUPPORT tools
and the ways in which they can be used are described in more
detail in the Introduction to this series [1]. A glossary for the
entire series is attached to each article (see Additional File 1).
Links to Spanish, Portuguese, French and Chinese translations
of this series can be found on the SUPPORT website http://
www.support-collaboration.org). Feedback about how to
improve the tools in this series is welcome and should be sent to:
STP@nokc.no.
Scenario
There is a new Minister of Health in the Ministry where you
work. One of the goals of the new Minister is to improve the
capacity of the Ministry to use research evidence to inform deci-
sions about how the health system is organised, financed and
governed. You have been asked to put forward a proposal for
strategies to improve how the Ministry supports its use of evi-
dence to inform policy decisions.
Background
In this article, we present five questions that policymakers
and those who support them could ask when considering
how to improve support for the use of research evidence
to inform health policy decisions. Such questions could,
for instance, be asked by any of the people in the scenario
outlined above.
A number of theories have been proposed to explain the
role of research evidence in policymaking. In addition,
common wisdom about how to improve the appropriate
use of research evidence is abundant. However, empirical
evidence to support such ideas is difficult to find [2].
While increasing numbers of studies are being undertaken
in low- and middle-income countries [3-8] most evidence
still comes from interview studies in high-income coun-
tries [9,10]. Systematic reviews of these studies suggest
that [9,10]:
￿ Interaction between researchers and policymakers
increases the likelihood of research being used by pol-
icymakers
￿ Good timing and timely research increase (and poor
timing or lack of timeliness decrease) the likelihood of
research being used by policymakers
￿ When policymakers have negative attitudes towards
research evidence, the likelihood of research being
used by them decreases
￿ When policymakers lack relevant skills and exper-
tise, the likelihood of research being used by them
decreases
￿ Policy networks and trust in researchers increase the
likelihood of research being used by policymakers,
and
￿ A lack of perceived relevance, the use of jargon, and
the production of publications aimed at a scholarly
audience are all factors that decrease the likelihood of
research being used by policymakers
Activities aimed at improving the use of research evidence
to inform policy have been referred to in various ways.
These terms include: knowledge translation, knowledge
transfer, knowledge exchange, research utilisation, imple-
mentation, diffusion, and dissemination [11]. Considera-
ble confusion and misunderstanding exists about the
definition and scope of these concepts, and the literature
related to these issues is diverse and widely dispersed [12].
Several frameworks have been proposed as ways to organ-
ise these approaches and thus improve the use of research
evidence by policymakers [11-20]. These frameworks
have overlapping purposes and concepts.
One of these frameworks focuses on assessing country-
level efforts to link research to action. This framework pro-
vides an inventory of a range of activities that can be con-
sidered when developing organisational arrangements to
support the use of research evidence to inform health pol-
icy decisions [20]. It includes four elements: the general
climate for research use, the production of research that is
both highly relevant to – and appropriately synthesised
for – policymakers, the mix of efforts used to link research
to action, and the evaluation of efforts to link research to
action. Within this framework, efforts to link research to
action are categorised in four clusters of activities. These
are: push efforts (efforts to communicate research findings
which may include, for example, the tailoring of messages
by researchers according to policymaker needs), efforts to
facilitate user pull (such as rapid-response units to meet
policymaker needs for research evidence), user pull (efforts
to facilitate research use, such as efforts to train policy-
makers in how to access research evidence), and exchange
efforts (partnerships between researchers and policymak-
ers in which relevant questions are jointly asked and
answered).
Little is known about how best to organise such a range of
activities and, until recently, relatively few organisations
were responsible for supporting the use of research evi-
dence in developing health policy [21,22]. The questions
that we propose in this article focus on the lessons learned
from the experience of organisations engaged in activitiesHealth Research Policy and Systems 2009, 7(Suppl 1):S2 http://www.health-policy-systems.com/content/7/S1/S2
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to support evidence-informed health policymaking [21].
The evidence from which these lessons were drawn was
collected from a survey of 176 organisations, followed by
telephone interviews with 25 of these, and site visits to
eight. The lessons are:
￿ Establish strong links between policymakers and
researchers, and involve stakeholders in the work
undertaken
￿ Be independent and manage conflicts of interest
among those involved in the work
￿ Use appropriate methods and be transparent in the
work
￿ Collaborate with other organisations
￿ Start small, have a clear audience and scope, and
address important questions
￿ Build capacity among those working in the organisa-
tion
￿ Be attentive to implementation considerations even
if implementation is not a remit
Questions to consider
Drawing on the above lessons, we suggest five questions
that can be asked when considering how to improve sup-
port for the use of research evidence to inform health pol-
icy decisions. These questions address key strategies to
improve how support for evidence-informed health poli-
cymaking is organised, as illustrated in Figure 1. They do
not address broader questions about government policy-
making processes and how these can be designed to pro-
mote the use of evidence. The questions are:
1. What is the capacity of your organisation to use
research evidence to inform decision making?
2. What strategies should be used to ensure collabora-
tion between policymakers, researchers and stake-
holders?
3. What strategies should be used to ensure independ-
ence as well as the effective management of conflicts of
interest?
4. What strategies should be used to ensure the use of
systematic and transparent methods for accessing,
appraising and using research evidence?
5. What strategies should be used to ensure adequate
capacity to employ these methods?
1. What is the capacity of your organisation to use 
research evidence to inform decision making?
In order for organisations to improve the degree to which
their decisions are well-informed by research evidence,
sufficient capacity is needed to recognise the need for
research evidence. This is necessary for acquiring research
when it is needed, critically appraising it, using it to
inform decisions, and measuring the impacts of policies
and programmes that are implemented [20,23-27].
Capacities in these different areas vary widely both in gov-
ernmental and non-governmental organisations [21,28].
A first step in the process of improving organisational
capacity is therefore the assessment of an organisation’s
current capacity.
There are a number of validated instruments for measur-
ing the competence of individuals to practice evidence-
based medicine e.g.[29-31]. However, in this article, our
focus is on organisational capacity rather than the compe-
tence of individuals. The Canadian Health Services
Research Foundation (CHSRF) has developed a self-
assessment tool for healthcare organisations to assist in
identifying ways in which research can be gathered and
used, as well as potential ways in which this can be
improved [23,24,32,33]. This tool includes four key areas
for the assessment of research use: the acquisition, assess-
ment, adaptation and application of evidence. Lavis and
colleagues have proposed a framework for assessing coun-
try-level efforts to link research to action [20]. Their
framework includes a number of areas not covered by the
CHSRF tool [23]. These include the extent to which the
general environment supports the linking of research to
action, the production of research, efforts to communicate
Strategies to improve how support for evidence-informed  health policymaking is organised Figure 1
Strategies to improve how support for evidence-informed 
health policymaking is organised
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research findings (so-called ‘push’ strategies), and efforts
to facilitate the use of research findings (so-called ‘user
pull’ factors).
The self-assessment tool that we present in Additional File
2 draws on both of these frameworks, and the CHSRF tool
in particular. It addresses the key steps needed to ensure
the appropriate use of research evidence to inform deci-
sions related to health policies and programmes. This tool
is intended to help organisations assess and improve their
capacity to use research evidence. It has not been formally
tested. Instead, it has evolved through iterative revisions
based on workshops involving a variety of groups.
Additional File 2 is a ‘scorecard’ intended to provide the
basis for discussion and for reaching agreement about the
priorities and strategies needed for improvement. Often
people in the same organisation have divergent percep-
tions of how well the organisation is doing. This is illus-
trated in Additional File 3, which summarises the
application of a scorecard to the assessment of an organi-
sation’s performance. Identifying and discussing these
discrepancies can help to develop a shared vision and a
plan of action. The scorecard shown in Additional File 2
can be applied across departments in a large organisation
(as highlighted in the illustrative example shown in Addi-
tional File 3), as well as within a department, or a combi-
nation of both. The scorecard can also be used to monitor
how well an organisation is doing in its efforts to improve
its use of research evidence.
2. What strategies should be used to ensure collaboration 
between policymakers, researchers and stakeholders?
Many organisations that support the use of research evi-
dence in policymaking commonly involve policymakers
in the selection of topics and the services undertaken. Per-
sonal communication between policymakers and
researchers has been found to be particularly important,
both by policymakers and those who support their use of
research evidence [21]. Organisations that support evi-
dence-informed policymaking view their close links with
policymakers as a strength [21]. However, this strength
brings with it a related challenge: the need to manage con-
flicts of interest that can emerge in any close relationship
between researchers and policymakers.
Strategies that can help to ensure collaboration between
policymakers and researchers include:
￿ Locating those who support the use of research by
policymakers (by accessing, appraising and summaris-
ing evidence) within or close to those organisations
responsible for policymaking
￿ Involving policymakers on an advisory board or
steering committee in instances when organisations
are located outside government or policymaking
organisations
￿ Formal agreements linking academic organisations
to policymaking organisations
￿ Using trusted individuals as ‘knowledge brokers’ to
build relationships among researchers and policymak-
ers [34]
￿ Involving policymakers in research processes such as
the preparation of policy briefs [35]
￿ Involving researchers in policy-informing processes
such as policy dialogues [36]
￿ Skill development programmes for both policymak-
ers and researchers [37-39] including exchanges where
researchers are seconded to a policymaking organisa-
tion and policymakers are seconded to a research
organisation
An illustration of the need to manage potential tensions
between policymakers and researchers who are working
together is provided in Table 1.
Organisations that support the use of research evidence in
policymaking also frequently cite the involvement of
stakeholders as a key strength [21]. Stakeholder organisa-
tions include, for example, patient organisations, commu-
nity groups, coalitions, advocacy groups, faith-based
organisations, charities or voluntary organisations, pro-
fessional associations, trade unions and business associa-
tions [40].
However, managing stakeholder involvement can be both
challenging and demanding. There is a paucity of evi-
dence comparing alternative ways of involving stakehold-
ers in policymaking or research processes including [41]:
￿ The degree of involvement (consultation or collabo-
ration)
￿ Different forums for communication (e.g. commit-
tee membership, permanent panels, town meetings,
interviews, written consultation)
￿ Different methods for recruiting stakeholders (e.g.
targeted personal invitations, advertisements, or the
use of mass media)
￿ Different ways of training and supporting consumers
or other stakeholders to ensure effective involvementHealth Research Policy and Systems 2009, 7(Suppl 1):S2 http://www.health-policy-systems.com/content/7/S1/S2
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￿ Different degrees of financial support to facilitate the
involvement of consumers or other stakeholders
There is a range of different types of collaboration that
may be appropriate for different stakeholders. For some
groups, ongoing interaction may be more useful than
involving them directly in policymaking (e.g. groups that
have an interest in one aspect of a policy, such as profes-
sional regulatory issues). For other groups, it may be desir-
able to keep them at arms length (e.g. pharmaceutical
companies with a vested interest in a policy decision). For
certain groups, it may be justifiable to exclude them com-
pletely from deliberations (e.g. tobacco companies that
have falsified research results on the harmful effects of
tobacco).
Strategies that can help to ensure appropriate levels of
stakeholder involvement are similar to those highlighted
above for ensuring collaboration between policymakers
and researchers. These may include, for example, the
involvement of stakeholders on an advisory board or
steering committee, in research processes, and in policy-
making processes. They may also include consultation
with stakeholder groups, the use of skill-development
programmes for stakeholders [42-44], and the communi-
cation of evidence to the wider public via the mass media
[45].
An example of the use of extensive strategies for involving
stakeholders by a public agency is provided in Table 2.
3. What strategies should be used to ensure independence 
as well as the effective management of conflicts of 
interest?
Independence is the most commonly cited strength of
organisations that support the use of research evidence in
policymaking [21]. Conversely, conflicts of interest are
seen as a key weakness. Financial and intellectual inde-
pendence and freedom from government and industry
influence are viewed as the key strengths of such organisa-
tions. But these need to be balanced against the desirabil-
ity of arrangements that can ensure collaboration between
policymakers and researchers. Independence is, of course,
relative. No organisation is entirely independent.
Mutually agreed processes and methods are essential in
order to manage possible competing tensions arising from
the demands of both collaboration and independence.
They are also important as ways to ensure the systematic
and transparent access and appraisal of evidence as an
input into the policymaking process.
Conflicting interests frequently underlie tensions arising
between policymakers, researchers and other stakehold-
ers. Although there is little empirical evidence to guide
arrangements for managing conflicts of interest, the key
options that warrant consideration include [46]:
￿ Specific, detailed, structured disclosure forms that
solicit as much information as possible about the
nature and extent of competing interests. Minimal or
open-ended formats for disclosure forms are likely to
be uninformative
￿ Explicit criteria to make decisions easier about
whether a disclosed interest constitutes a conflict of
interest
￿ A range of management strategies to address dis-
closed conflicts of interest, ranging from the public
disclosure of conflicts associated with each meeting as
a minimum prerequisite, through to the recusal of
conflicted individuals as the most extreme measure
￿ A standard policy requiring all financial ties to be
made public (e.g. that they be recorded in meeting
minutes), may reduce the number of problematic
cases
￿ A standing committee to review all financial disclo-
sure statements prior to the commencement of com-
mittee meetings or hearings, to make management
recommendations when necessary, and which can
help to ensure that conflict of interest policies are
enforced
Organisational arrangements should ensure responsive-
ness to the information needs of policymakers. At the
same time, it is important to ensure independence with
Table 1: A case study of the need to manage tensions between policymakers and researchers in a long-term collaboration
Since the early 1990s, policymakers in the provincial government of the Free State in South Africa have worked closely with researchers on health 
and health policy-related topics, including the monitoring and evaluation of antiretroviral (ARV) therapy rollouts [21]. The evidence from these 
studies has exposed major deficiencies in the ARV rollout, and concerns have been raised that if the research findings become too critical, the 
privileged data access offered to researchers, and the collaboration offered on evaluations, may simply end. This has led to tensions in the 
relationship between the researchers and the provincial Health Department with both sides being very direct about these concerns. While 
acknowledging that it is challenging to manage the tensions, both the policymakers and the researchers are committed to learning how to manage 
this kind of conflict. From the Health Department’s perspective, this is essential in order to evaluate and improve the services delivered by the 
provincial government. From the researchers’ perspective, this is motivated by “a feeling that you are doing research that is actually relevant and 
addressing actual needs as opposed to just driving publications” [21].Health Research Policy and Systems 2009, 7(Suppl 1):S2 http://www.health-policy-systems.com/content/7/S1/S2
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respect to the methods used to access, appraise and sum-
marise research evidence. Arrangements to ensure that
independence is maintained may include:
￿ Financial arrangements that minimise the risk of
inappropriate influence on what evidence is summa-
rised, or how it is summarised
￿ Management arrangements, including the involve-
ment of independent stakeholders in advisory boards
or steering groups
￿ Mechanisms for managing disputes such as inde-
pendent arbitrators or appeal processes, particularly
for governmental agencies that fund the work and for
industry
￿ Ensuring that decision making is transparent in
terms of how evidence is accessed, appraised, summa-
rised and publicly reported
4. What strategies should be used to ensure the use of 
systematic and transparent methods for accessing, 
appraising and using research evidence?
The majority of organisations supporting the use of
research evidence in policymaking use systematic reviews
[21]. In addition to their independence, such organisa-
tions commonly state that their use of systematic and
transparent methods (sometimes they are referred to as
“being evidence-based”) is one of their key strengths.
However, organisations that support governments to use
research evidence in the development of health policies
and programmes are less likely to have guidelines describ-
ing the methods they use. They are also less likely to con-
duct or use systematic reviews relative to organisations
that produce health technology assessments (HTAs) or
clinical practice guidelines. In addition, using systematic
and transparent methods brings a related challenge: the
time-consuming nature of using more rigorous methods.
As a consequence, many organisations, particularly HTA
agencies, have attempted to develop more rapid methods
that are “quick but clean enough” [47].
Given that evidence-informed health policymaking is
characterised by the use of systematic and transparent
methods to access and appraise evidence as an input into
the policymaking process, it therefore follows that the use
of agreed-upon methods for doing this is key for any
organisational arrangement to support evidence-
informed policymaking. Such methods should be
described in easily accessible documents. Moreover,
although organisational arrangements are likely to vary
widely, a great deal of commonality in the methods that
are used is likely, as is the case for clinical practice guide-
lines, for example [48]. Thus, in addition to helping to
ensure the use of agreed-upon methods, accessible manu-
als that describe these methods can also benefit other
organisations with similar interests.
Stakeholders who feel that they have lost out as the result
of a particular decision are still likely to challenge the
methods used if there is a substantial amount at stake,
irrespective of the rigour and transparency applied. None-
theless, the use of agreed-upon methods that are
described in easily accessible form can make it easier to
respond to such challenges.
Table 2: An example of stakeholder involvement in healthcare decisions: the National Institute for Health and Clinical Excellence 
(NICE)
Few organisations have sought to integrate stakeholders (especially patients and their caregivers) more thoroughly than the National Institute for 
Health and Clinical Excellence (NICE) in England and Wales [50]. NICE has created effective strategies to involve stakeholder groups including [50-
52]:
• A programme within the Institute with dedicated staff responsible for patient and public involvement
• The identification and recruitment of stakeholders, including lay people, to NICE’s independent advisory committees
• The provision of training and support to lay people on NICE’s committees
• The registration of stakeholder groups, which are then routinely consulted electronically and through meetings
• The involvement of stakeholders throughout the development of guidance and decisions from topic selection to reviews of draft guidance, 
through to consultation and active participation on committees
• Systematic and transparent responses to stakeholders’ comments on drafts
• The development and dissemination of lay versions of NICE’s guidance, versions for key stakeholder groups, and mass media briefings, as well as 
versions for clinicians and managers, and
• The involvement of stakeholders in guidance implementation 
NICE’s experience suggests that the involvement of stakeholders in healthcare decision making is possible and can work well, but requires strong 
commitment and specific arrangements. It can also be costly. Although NICE’s investment in stakeholder involvement is widely valued, it is 
uncertain whether the right stakeholders are involved, both in terms of which stakeholder groups engage in the process and in terms of the extent 
to which the individuals who become involved appropriately represent various stakeholders. It is also uncertain whether the strategies they use are 
as efficient as they could be – in other words, whether the resources invested in those processes represent good value for money [51]. There are 
also concerns about the growing burden of managing stakeholder input. Although the number of submissions from stakeholders has been 
increasing, involvement at the individual level within stakeholder organisations may be less than desired.Health Research Policy and Systems 2009, 7(Suppl 1):S2 http://www.health-policy-systems.com/content/7/S1/S2
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An illustration of efforts to ensure the use of systematic
and transparent methods to develop recommendations
and policies is provided in Table 3.
5. What strategies should be used to ensure adequate 
capacity to employ these methods?
The most commonly cited weakness of organisations that
support the use of research evidence in policymaking are
a lack of financial and human resources. How adequate
funding for supporting the use of research evidence can be
ensured is a major challenge, particularly in low- and mid-
dle-income countries. Partly, this may be because this
function falls between two stools – it is typically not
funded by research funders, or by those interested in
strengthening policymaking. Identifying appropriate
sources of funding is critical to developing and sustaining
adequate capacity for supporting evidence-informed
health policymaking.
Three of the key messages that emerged from a review of
these organisations relate to ensuring adequate capacity
[21,49]:
￿ Collaborate with other organisations, both infor-
mally and formally, to learn from their experience in
order to avoid the unnecessary duplication of efforts,
to draw on their capacity, and to help build capacity
(see Table 4 for examples of international collabora-
tion)
￿ Build capacity among those working in the organisa-
tion through training, making the best use of available
staff (numbers are often limited), and actions aimed at
retaining skilled staff, and
￿ Start small, have a clear scope, and address impor-
tant questions in order to ensure that available
resources are focused on areas where they are needed
most
As noted above, another strategy that many organisations
identified was the use of more rapid methods that are rig-
orous but less resource-intensive – especially those that
would result in a reduction in the time required of skilled
staff.
Conclusion
A scorecard, such as the one shown in Additional File 2,
can be used to assess the capacity of an organisation to
support its use of research evidence. This can provide a
useful basis for discussion and for establishing consensus
about an organisation’s strengths, weaknesses, priorities
and the strategies necessary for improvement. Although
people in the same organisation often have divergent
views about how well it is performing, identifying and dis-
cussing these discrepancies can help to develop a shared
vision and plan of action. This may be achieved, for exam-
ple, by sharing information within or across different sec-
tions or levels within the organisation, clarifying what
different sections of the organisation can or should be
doing, addressing misunderstandings, resolving commu-
nication problems or identifying information that is
needed to resolve disagreements.
There is limited evidence regarding the effects of different
strategies to improve how support for evidence-informed
health policymaking is organised. Organisational arrange-
ments should logically be tailored to address specific aims
and circumstances. Nonetheless, a number of lessons can
be drawn from the experience of organisations around the
world. Reflection on the questions discussed in this article
can help policymakers and those who support them to
improve organisational arrangements supporting the use
of research evidence to inform health policy decisions.
Resources
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Table 3: An example of ensuring the use of systematic and transparent methods in an international organisation
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• Developing checklists for assessing recommendations and plans for developing recommendations based on the manual
• Establishing a secretariat and a network to provide training and support to implement the methods described in the manual, and
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http://www.scielosp.org/scielo.php?pid=S0042-
96862006000800013&script=sci_arttext&tlng=en
- EUnetHTA Work Package 8. EUnetHTA Handbook
on Health Technology Assessment Capacity Building.
Barcelona: Catalan Agency for Health Technology
Assessment and Research. Catalan Health Service.
Department of Health Autonomous Government of
Catalonia; 2008. http://www.gencat.cat/salut/depsan/
units/aatrm/pdf/
eunethta_wp8_hb_hta_capacity_building.pdf
- Thornhill J, Judd M, Clements D. CHSRF Knowledge
Transfer: (Re)introducing the self-assessment tool that
is helping decision-makers assess their organization’s
capacity to use research. Healthc Q 2008; 12:22-4.
http://www.longwoods.com/product.php?produc
tid=20410
Links to websites
- Evidence-Informed Policy Network (EVIPNet): http:/
/www.evipnet.org/php/index.php – EVIPNet pro-
motes the systematic use of health research evidence
in policymaking. Focusing on low- and middle-
income countries, EVIPNet promotes partnerships at
the country level between policymakers, researchers
and civil society in order to facilitate both policy devel-
opment and policy implementation through the use
of the best scientific evidence available. EVIPNet com-
prises networks that bring together country-level
teams, which are coordinated at both regional and
global levels.
- Alliance for Health Systems Policy and Research:
http://www.who.int/alliance-hpsr/en/ –The Alliance
for Health Policy and Systems Research is an interna-
tional collaboration based in the WHO, Geneva. It has
its origins in the recommendations of the 1996 report
of WHO’s Ad Hoc Committee on Health Research
which identified a lack of health policy and systems
research as a key problem impeding the improvement
of health outcomes in low- and middle-income coun-
tries. It aims to promote the generation and use of
health policy and systems research as a means to
improve the health systems of developing countries.
- Canadian Health Services Research Foundation:
http://www.chsrf.ca – The Foundation brings
researchers and decision makers together to create and
apply knowledge to improve health services for Cana-
dians. It is an independent, not-for-profit corporation,
established with endowed funds from the federal gov-
ernment and its agencies.
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Table 4: Examples of collaborations with other organisations
The following are examples of international collaborations that help to build capacity and support for the use of research evidence in health 
policymaking:
EVIPNet (the Evidence Informed Policy Network) – initiated by the World Health Organization and the Ministries of Health in 25 countries, 
its aim is to promote the use of research evidence in health policy formulation in order to strengthen health systems [22,56]. At the country level, 
EVIPNet takes the form of partnerships between policymakers, researchers and civil society and focuses on facilitating the use of research evidence. 
Launched in 2005, EVIPNet now supports activities in Africa, Asia and the Americas.
Region of East Africa Community Health (REACH) policy initiative – established within the East African Community (EAC) (Kenya, 
Tanzania and Uganda, with the recent addition of Rwanda and Burundi) to bridge the gap between evidence and health policy and practice [57]. Its 
mission is to access, synthesise, package and communicate evidence required for policy and practice and to influence policy-relevant research 
agendas for improved population health and health equity in each of the member countries.
Reforming States Group (RSG) – since 1991, leaders in health policy from the legislative and executive branches of state government, with the 
financial support and staff collaboration of the Milbank Memorial Fund, have shared their experiences and have worked on practical solutions to 
shared healthcare problems. They have focused increasingly on the use of research evidence to inform health policy decisions [38,39,58]. The RSG 
now also includes members outside the United States of America. The Center for Evidence-based Policy, which works with RSG members, was 
established in 2003 by former Oregon Governor, John Kitzhaber, to address public policy challenges by identifying and applying the best available 
evidence through self-governing communities of interest [59].
Cochrane Collaboration – a global network whose aim is to improve healthcare decision making through the preparation and updating of 
systematic reviews of the effects of healthcare interventions. The Cochrane Collaboration ensures that these reviews are made accessible. See 
http://cochrane.org/Health Research Policy and Systems 2009, 7(Suppl 1):S2 http://www.health-policy-systems.com/content/7/S1/S2
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